(Q24198110)

3

object named as

Valeria Aoki

0 references

Jade Cury Martins

1

object named as

Jade Cury Martins

0 references

author name string

Ciro Martins

2

0 references

Aecio FT Gois

5

0 references

Henrique Akira Ishii

6

0 references

Edina MK da Silva

Cochrane Database of Systematic Reviews

7

0 references

publication date

16 May 2012

0 references

published in

0 references

cites work

Efficacy and tolerability of topical pimecrolimus and tacrolimus in the treatment of atopic dermatitis: meta-analysis of randomised controlled trials

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009864

Topical pimecrolimus for eczema

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009864

Which population level environmental factors are associated with asthma, rhinoconjunctivitis and eczema? Review of the ecological analyses of ISAAC Phase One.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009864

Dietary exclusions for established atopic eczema

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009864

Atopic eczema or atopiform dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009864

The course of life of patients with childhood atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009864

Effects of atopic dermatitis on young American children and their families

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009864

Meta-analyses involving cross-over trials: methodological issues

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009864

Diet and asthma, allergic rhinoconjunctivitis and atopic eczema symptom prevalence: an ecological analysis of the International Study of Asthma and Allergies in Childhood (ISAAC) data. ISAAC Phase One Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009864

Atopic dermatitis and nutrition

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009864

Eczema, atopy and allergen exposure in adults: a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009864

Measuring inconsistency in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009864

Revised nomenclature for allergy for global use: Report of the Nomenclature Review Committee of the World Allergy Organization, October 2003.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009864

Balancing efficacy and safety in the management of atopic dermatitis: the role of methylprednisolone aceponate

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009864

Superantigens in dermatology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009864

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009864

The Safety and Efficacy of Tacrolimus Ointment in Pediatric Patients with Atopic Dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009864

Inhibitory potency of tacrolimus ointment on skin tumor induction in a mouse model of an initiation-promotion skin tumor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009864

Global variations in prevalence of eczema symptoms in children from ISAAC Phase Three.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009864

Efficacy and tolerability of proactive treatment with topical corticosteroids and calcineurin inhibitors for atopic eczema: systematic review and meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009864

Hay fever, hygiene, and household size

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009864

Evaluation of cancer risk related to atopic dermatitis and use of topical calcineurin inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009864

Malignancy concerns of topical calcineurin inhibitors for atopic dermatitis: facts and controversies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009864

Worldwide variations in the prevalence of symptoms of atopic eczema in the International Study of Asthma and Allergies in Childhood.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009864